scholarly journals Wang X, Haylock D, Hu CS, et al. A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells. Blood. 2016;127(26):3398-3409.

Blood ◽  
2017 ◽  
Vol 130 (25) ◽  
pp. 2809-2809
Blood ◽  
2016 ◽  
Vol 127 (26) ◽  
pp. 3398-3409 ◽  
Author(s):  
Xiaoli Wang ◽  
David Haylock ◽  
Cing Siang Hu ◽  
Wioleta Kowalczyk ◽  
Tianbo Jiang ◽  
...  

Key Points Treatment of MF CD34+ cells with a TPO receptor antagonist selectively depletes MF HSCs and HPCs. Agents that target the TPO receptor represent potentially new approaches for the treatment of MF patients.


2001 ◽  
Vol 38 (2) ◽  
pp. 139-147
Author(s):  
Jan W. Gratama ◽  
D. Robert Sutherland ◽  
Michael Keeney

Leukemia ◽  
2021 ◽  
Author(s):  
Neta Nevo ◽  
Lizeth-Alejandra Ordonez-Moreno ◽  
Shiri Gur-Cohen ◽  
Francesca Avemaria ◽  
Suditi Bhattacharya ◽  
...  

2020 ◽  
Vol 88 ◽  
pp. S46
Author(s):  
Oakley Olson ◽  
Fernando Calero-Nieto ◽  
Xiaonan Wang ◽  
Bethold Göttgens ◽  
Emmanuelle Passegué

Sign in / Sign up

Export Citation Format

Share Document